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Cancer that is detected in its early stages can give patients more options and
save thousands of dollars in medical costs. Some of the most recent
developments in computer science and machine learning are in the biomedical
field, especially individualized healthcare. There is also an increase in the
demand for telehealth options, reducing healthcare costs. With the help of
computational technology, medical practitioners will be able to process data
more quickly, which will allow more patients to have access to reliable treatment.
Besides, systematic processes for interpreting various data types (such as
clinical features, genetic information, and medical images) can identify trends
that a human eye would not detect.
ConclusionsModel
Introduction
We created a prototype for a model that took in 3D MRI images containing
different scans of breast cancer. The model is a shallow 3D Convolutional
Neural Network that accepts numpy array inputs with the shape (1 x 256 x 256 x
36).
BreastNet contributes to a growing body of studies that use machine learning to
help cancer patients understand their diagnosis and make informed treatment
decisions. By understanding whether they have a high or low risk of death within
the next five years, they will have agency to maximize their quality of life. By
focusing on specific results that patients find most important when learning
about their breast cancer diagnosis, BreastNet can help make a positive impact
on people’s lives; one that goes beyond the simple results the program
generates.
When patients are diagnosed with breast cancer, it is important for them to
understand how serious the disease is, and they rely on experts like doctors
and radiologists to interpret a wide range of medical data in their record, which
includes high quality images as well as clinical data and patient history. By
understanding the risk score of high and low risk, the patients are able to make
the right decisions about their future treatment plans. CNNs have the ability to
make use of medical images from a variety of sources to aid in the diagnosis
and prognosis of diseases like cancer. Since breast cancer is so common in
women, there are large publicly available datasets that contain a large number
of Magnetic Resonance Images (MRI). The I-SPY clinical trial was used to
train BreastNet, and it is a publicly available dataset which is available through
The Cancer Imaging Archive.
The initial datasets were composed of folders containing slices of DICOM data
that were organized by patient, time relative to treatment, and view type (eg.
Scout, Sagittal, etc). Since the model was constructed using Keras and
Tensorflow libraries, we needed a data that was in a standardized format for
quick array processing. We created a preprocessing program using the pydicom
library to convert a DICOM directory from a series of 2D Sagittal view images to
a 3D numpy array. We also processed a separate "region of interest" (ROI)
image, which was provided by radiologists, into a sparse 3D numpy array. The
ROI could be used as a bitmap, which can be used to focus the training of the
model on image details directly related to the breast cancer tumors, which can
reduce some of the noise found in the high-dimensional data. Some of the
benefits of using 3D numpy arrays include the fact that it can be sliced in any
number of dimensions, and that it can be easily processed by python scripts,
which can open the problem of medical image analysis to include computer
scientists who use python as their primary tools of choice.
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How well can we predict the 5 year life expectancy of Breast cancer based on 
patients’ MRI and clinical data?
We used MRI and clinical data from publicly available datasets found through 
The Cancer Imaging Archive. The ACRIN I-SPY clinical trial included MRI 
images and survival information that was used to model a binary classifier 
based on censored survival data. Data was processed into training and test 








We created a prototype for a model that took in 3D MRI images containing
different scans of breast cancer. The model is a shallow 3D Convolutional
Neural Network that accepts numpy array inputs with the shape (1 x 256 x 256 x
36).
Some of the major challenges related to this project include the fact that Keras does
not natively support 3D image preprocessing. Some of these steps must be done. As a
result, we needed to use custom libraries to generate data to train the network.
